| |
| |
|
| Insider
Information: |
Watkins Thomas |
| Relationship: |
Director |
| City: |
Rockville |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
63,064 |
|
|
Indirect Shares
|
66,000 |
|
|
| Direct
Value |
$338,023 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
129,064 |
|
|
| Total
Value |
$338,023 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 43.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Human Genome Sciences Inc |
HGSI |
Chief Executive Office... |
2012-07-30 |
0 |
2011-01-05 |
66,000 |
Premium* |
|
|
Vanda Pharmaceuticals Inc. |
VNDA |
Director |
2022-06-02 |
63,064 |
2014-03-14 |
0 |
Premium* |
|
|
Horizon Pharma, Inc. |
HZNP |
Director |
2023-10-06 |
0 |
2023-10-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
47 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HGSI |
Human Genome Sciences Inc |
Chief Executive Officer |
• • – |
2005-01-05 |
4 |
B |
$11.95 |
$119,500 |
D/D |
10,000 |
10,000 |
2.81 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Chief Executive Officer |
• • – |
2006-09-05 |
4 |
B |
$11.14 |
$334,200 |
D/D |
30,000 |
40,000 |
2.81 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Chief Executive Officer |
• • – |
2006-11-10 |
4 |
B |
$12.05 |
$72,300 |
I/I |
6,000 |
6,000 |
2.66 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Chief Executive Officer |
• • – |
2007-07-11 |
4 |
B |
$7.59 |
$15,126 |
D/D |
1,993 |
41,993 |
2.81 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Chief Executive Officer |
• • – |
2008-03-11 |
4 |
B |
$4.93 |
$98,700 |
D/D |
20,000 |
61,993 |
2.81 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Chief Executive Officer |
• • – |
2008-07-01 |
4 |
B |
$4.49 |
$10,242 |
D/D |
2,281 |
64,274 |
2.81 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Chief Executive Officer |
• • – |
2008-11-12 |
4 |
B |
$2.02 |
$202,000 |
D/D |
100,000 |
164,274 |
2.81 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Chief Executive Officer |
• • – |
2009-06-30 |
4 |
B |
$1.80 |
$1,800 |
D/D |
1,000 |
165,274 |
2.73 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Chief Executive Officer |
• • – |
2010-07-12 |
4 |
B |
$19.64 |
$15,737 |
D/D |
801 |
166,075 |
2.81 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Chief Executive Officer |
• • – |
2010-11-02 |
4/A |
GA |
$0.00 |
$0 |
D/D |
2,000 |
168,075 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Chief Executive Officer |
• • – |
2011-01-05 |
4 |
B |
$24.16 |
$1,449,600 |
I/I |
60,000 |
66,000 |
2.66 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Chief Executive Officer |
• • – |
2011-06-30 |
4/A |
B |
$20.62 |
$21,239 |
D/D |
1,030 |
169,105 |
2.81 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Chief Executive Officer |
• • – |
2011-11-07 |
4/A |
GA |
$0.00 |
$0 |
D/D |
5,000 |
174,105 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Chief Executive Officer |
• • – |
2012-06-29 |
4/A |
B |
$6.32 |
$21,260 |
D/D |
3,364 |
177,469 |
2.81 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Chief Executive Officer |
• • – |
2012-07-25 |
4 |
GD |
$14.25 |
$2,366,570 |
D/D |
166,075 |
0 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Chief Executive Officer |
• • – |
2012-07-25 |
4/A |
GD |
$0.00 |
$0 |
D/D |
167,000 |
10,469 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Chief Executive Officer |
• • – |
2012-07-30 |
4/A |
D |
$14.25 |
$149,185 |
D/D |
(10,469) |
0 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Director |
– • – |
2014-03-14 |
4 |
OE |
$9.40 |
$329,000 |
D/D |
35,000 |
35,000 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Director |
– • – |
2014-03-14 |
4 |
S |
$17.66 |
$618,170 |
D/D |
(35,000) |
0 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2014-08-14 |
4 |
B |
$9.76 |
$58,560 |
D/D |
6,000 |
6,000 |
2.39 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2014-09-19 |
4/A |
D |
$0.00 |
$0 |
D/D |
(6,000) |
0 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2014-09-19 |
4/A |
A |
$0.00 |
$0 |
D/D |
6,000 |
6,000 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2015-08-19 |
4 |
B |
$31.32 |
$313,240 |
I/I |
10,000 |
10,000 |
2.1 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2016-05-06 |
4 |
OE |
$0.00 |
$0 |
I/I |
5,258 |
5,258 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2017-05-03 |
4 |
OE |
$0.00 |
$0 |
I/I |
13,953 |
19,211 |
0 |
- |
|
47 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
